Skip to main content
Back
finqOS
Search a stock, list or screen
⌘K
Not investment advice
Read full disclaimer
SMMT
———
Overview
Company
Financials
Valuation
News
Ownership
Documents
SMMT: Summit Therapeutics Inc. Stock Analysis | finqOS
SMMT
$9.95
−5.87%
Lists
Call SMMT
Summit Therapeutics
SMMT
Back
Lists
Call SMMT
$9.95
−$0.62 · −5.87%
Closed
Overview
Company
Financials
Valuation
News
Ownership
Documents
Down
24%
in three months and at its 52-week low.
Call SMMT
Loading chart data...
Signal state